Patents by Inventor Nicolas Wurtz

Nicolas Wurtz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds as inhibitors of factor VIIa
    Patent number: 7576098
    Abstract: The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel heterocyclic compounds, or a stereoisomer or pharmaceutically acceptable salt, solvate, or prodrug form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: August 18, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Peter W. Glunz, Nicolas Wurtz, Xuhong Cheng
  • Heterocyclic compounds as inhibitors of factor VIIa
    Publication number: 20060211720
    Abstract: The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel heterocyclic compounds, or a stereoisomer or pharmaceutically acceptable salt, solvate, or prodrug form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
    Type: Application
    Filed: December 7, 2005
    Publication date: September 21, 2006
    Inventors: Peter Glunz, Nicolas Wurtz, Xuhong Cheng